UK markets close in 7 hours 58 minutes

Rapid Micro Biosystems, Inc. (RPID)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
0.8200-0.0050 (-0.61%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
23,095
22,519
17,133
23,232
16,077
-
Cost of revenue
28,313
28,004
25,673
30,973
24,148
-
Gross profit
-5,218
-5,485
-8,540
-7,741
-8,071
-
Operating expenses
Research development
13,509
12,820
12,866
9,781
6,531
-
Selling general and administrative
37,237
38,258
41,813
29,710
15,938
-
Total operating expenses
50,746
51,078
54,679
39,491
22,469
-
Operating income or loss
-55,964
-56,563
-63,219
-47,232
-30,540
-
Interest expense
-
-
-
2,650
3,447
2,375
Total other income/expenses net
-101
-83
59
-23,593
-2,957
-
Income before tax
-51,875
-52,436
-61,382
-73,433
-36,944
-
Income tax expense
27
31
-576
91
134
-
Income from continuing operations
-51,902
-52,467
-60,806
-73,524
-37,078
-
Net income
-51,902
-52,467
-60,806
-73,524
-37,078
-
Net income available to common shareholders
-51,902
-52,467
-60,806
-78,032
-45,221
-
Basic EPS
-1.34
-
-1.43
-3.94
-1.42
-0.99
Diluted EPS
-1.34
-
-1.43
-3.94
-1.42
-0.99
Basic average shares
42,890
-
42,454
19,784
31,746
26,963
Diluted average shares
42,890
-
42,454
19,784
31,746
26,963